M CL2 (Carbidopa and levodopa 25 mg / 100mg)

Pill imprint M CL2 has been identified as Carbidopa and levodopa 25 mg / 100mg.

Carbidopa/levodopa is used in the treatment of restless legs syndrome; parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M CL2

Carbidopa and levodopa 25 mg / 100mg M CL2
Carbidopa and levodopa 25 mg / 100mg M CL2
Carbidopa and levodopa
Imprint:
M CL2
Strength:
25 mg / 100mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0085
Inactive Ingredients:
crospovidone
hydroxypropyl cellulose (type h)
magnesium stearate
microcrystalline cellulose
corn starch
D&C Yellow No. 10

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)